MBOT
Microbot Medical Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$1.44
+0.00%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.9x
Market Cap
$96.72M
MomentumView details →
1D Return
+0.00%
YTD Return
−27.25%
RSI (14)
36.8
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.9x
Market Cap
$96.72M
RSI (14)
36.8
MomentumView details →
1D Return
+0.00%
YTD Return
−27.25%
SummaryUpdated Jun 1, 2026
Microbot Medical Inc. (NASDAQ:MBOT) is a pre-clinical medical device company founded in 2010 and based in Hingham, Massachusetts. The company specializes in developing robotic endoluminal surgery devices for minimally invasive surgical procedures. Since going public in 1992, Microbot has focused on creating innovative micro-robotic technologies for various medical applications, including treatments for hydrocephalus and endovascular interventions. The company maintains a strategic collaboration with Stryker Corporation, a major medical technology company, for technology co-development purposes.
Similar companies
Latest newsMore news →
Microbot Medical Inc. reported a second-quarter net loss of $0.08 per share, in line with the Zacks Consensus Estimate and narrower than the year-ago loss of $0.10 per share.24d agoMicrobot Medical Inc. won the Innovative Start-Up Award from Surgical Robotics Technology for its LIBERTY Endovascular Robotic System.71d agoMicrobot Medical announced that a globally recognized academic center in Pennsylvania has adopted its LIBERTY Endovascular Robotic System, expanding the company's footprint in the Northeast U.S.73d ago